Although FAK activates RAF/MEK/ERK mitogen-activated protein kinase (MAPK) signaling cascade to promote cell survival, in half of melanomas, including A375 and C32 cells, the function of FAK in triggering ERK is attenuated due to the activating BRAF V600E mutation [51,52]. This evidence concerns the gene PTK2 and melanoma.